Kidney Cancer Staging and Grading Criteria
Renal cell carcinoma staging is based on tumor size, lymph node involvement, and the presence of metastasis, and is divided into Stage I, Stage II, Stage III, and Stage IV.
The TNM staging system is used for renal cell carcinoma, categorized into Stage I, Stage II, Stage III, and Stage IV. T stands for tumor size, N indicates lymph node involvement, and M refers to distant organ metastasis. Higher stages correlate with increased risk of recurrence.
Stages I and II are considered early-stage renal cell carcinoma. The tumor is less than 7 cm in size and confined entirely within the kidney, with no spread to nearby lymph nodes or distant organs. Under medical guidance, open surgery or laparoscopic surgery may be performed to prevent recurrence and metastasis of kidney cancer.
Stage III represents intermediate-stage renal cell carcinoma, characterized by tumor spread to nearby structures such as regional lymph nodes, blood vessels within or near the kidney (e.g., renal vein or inferior vena cava), the collecting system of the kidney, or surrounding perirenal fat. Under physician supervision, treatment options may include targeted drugs such as sorafenib tablets or sunitinib tablets, or chemotherapy.
Stage IV indicates advanced renal cell carcinoma, where cancer has spread beyond the perirenal fat and may involve the adrenal gland above the kidney or other distant sites such as the brain, lungs, liver, or bones. Treatment options include cytoreductive nephrectomy or radiation therapy.
It is recommended that patients with renal cell carcinoma maintain a regular lifestyle, stay optimistic, take prescribed medications as directed, and seek prompt medical attention if any discomfort occurs.